ETV1 and prostate cancer: We selected ETV1 as a possible target of miR-17, due to the fact that its role in melanoma has not been fully elucidated ([43], [44], [45]) and studies of prostate cancer exhibited that ETV1 affects the migratory ability of the cells ([34], [41]).